Neurona Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE) (NCT06422923) | Neurona Therapeutics | 2024-11-14 |
| Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) (NCT05135091) | Neurona Therapeutics | 2022-06-16 |
Track Neurona Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.